SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001140361-23-047719
Filing Date
2023-10-11
Accepted
2023-10-11 09:27:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM ny20011256x13_posam.htm POS AM 19080
  Complete submission text file 0001140361-23-047719.txt   20179
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-264966 | Film No.: 231319566
SIC: 2834 Pharmaceutical Preparations